Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
6.09
-0.11 (-1.77%)
Sep 8, 2026, 11:05 AM EDT - Market open
Niki BioSolutions Market Cap
Niki BioSolutions has a market cap or net worth of $17.9 million as of September 8, 2026. Its market cap has increased by 35.41% in one year.
Market Cap
17.90M
Enterprise Value
19.57M
1-Year Change
35.41%
Ranking
Category
Stock Price
$6.09
ChartMarket Cap Chart
Since December 18, 2018, Niki BioSolutions's market cap has decreased from $415.79M to $17.90M, a decrease of -95.70%. That is a compound annual growth rate of -33.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 17.90M | 107.32% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 19.67M |
| Chemomab Therapeutics | 19.64M |
| Cyclerion Therapeutics | 19.58M |
| Pasithea Therapeutics | 19.38M |
| NewcelX | 19.35M |
| Enlivex | 19.23M |
| Dyadic International | 18.96M |
| NeuroSense Therapeutics | 18.89M |